Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) trials recruiting in North Carolina

Fewer than 3 recruiting trials found.

All Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
  NCT05652686 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill, Durham